login
login

Europe Daily Bulletin No. 13129

25 February 2023
Contents Publication in full By article 19 / 25
EU RESPONSE TO COVID-19 / Health
EMA recommends authorising Valneva vaccine as booster dose in adults in Europe and refusing authorisation for Lagevrio
Brussels, 24/02/2023 (Agence Europe)

The European Medicines Agency (EMA) published on Friday 24 February the main decisions of its Committee for Medicinal Products for Human Use (CHMP) and two decisions concerning medical products related to Covid-19.

On the one hand, CHMP recommends authorising the use of the inactivated and adjuvanted vaccine developed against Covid-19 byValneva (see EUROPE B12980A20) for use as a booster dose in adults aged 18-50 years.

In addition, the CHMP reviewed all data received in the context of...

Contents

Russian invasion of Ukraine
EXTERNAL ACTION
INSTITUTIONAL
SECTORAL POLICIES
ECONOMY - FINANCE - BUSINESS
EU RESPONSE TO COVID-19
NEWS BRIEFS